EPOCH is an intensive chemotherapy regimen used to treat aggressive non-Hodgkin lymphoma. It is often combined with the monoclonal antibody rituximab, in which case it is called R-EPOCH or EPOCH-R. Its component drugs are etoposide, a topoisomerase inhibitor; prednisolone, a corticosteroid; Oncovin, also known as vincristine, which prevents microtubule formation and mitosis; cyclophosphamide, an alkylating agent; and hydroxydaunorubicin, also known as doxorubicin, an anthracycline antibiotic that intercalates DNA.
Facts
EPOCH (Chemotherapy)
Filter Results1 entry
Connections
Treats
Source EPOCH (chemotherapy) (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/EPOCH_(chemotherapy), lead sectionQuote, https://en.wikipedia.org/wiki/EPOCH_(chemotherapy), lead section
EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin lymphoma.
EPOCH (chemotherapy) (Wikipedia)
Treats: Non-Hodgkin Lymphoma, Lead (280524)Quote, Treats: Non-Hodgkin Lymphoma, Lead (280524)
EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin lymphoma.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.